These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 34839111)
1. Direct Medical Cost of Type 2 Diabetes Mellitus and Its Associated Complications in Indonesia. Hidayat B; Ramadani RV; Rudijanto A; Soewondo P; Suastika K; Siu Ng JY Value Health Reg Issues; 2022 Mar; 28():82-89. PubMed ID: 34839111 [TBL] [Abstract][Full Text] [Related]
2. Direct medical costs of diabetes and its complications in Vietnam: A national health insurance database study. Tuan Kiet Pham H; Tuyet Mai Kieu T; Duc Duong T; Dieu Van Nguyen K; Tran NQ; Hung Tran T; Yi Siu Ng J Diabetes Res Clin Pract; 2020 Apr; 162():108051. PubMed ID: 32027924 [TBL] [Abstract][Full Text] [Related]
3. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting. Yeaw J; Halinan S; Hines D; Delozier A; Perez M; Boye M; Boye KS; Blanchette CM Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912 [TBL] [Abstract][Full Text] [Related]
4. How do type 2 diabetes mellitus (T2DM)-related complications and socioeconomic factors impact direct medical costs? A cross-sectional study in rural Southeast China. Wu H; Eggleston KN; Zhong J; Hu R; Wang C; Xie K; Chen Y; Chen X; Yu M BMJ Open; 2018 Nov; 8(11):e020647. PubMed ID: 30389755 [TBL] [Abstract][Full Text] [Related]
5. Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study. Giorda CB; Rossi MC; Ozzello O; Gentile S; Aglialoro A; Chiambretti A; Baccetti F; Gentile FM; Romeo F; Lucisano G; Nicolucci A; Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):209-216. PubMed ID: 28017523 [TBL] [Abstract][Full Text] [Related]
6. Direct non-medical and indirect costs of diabetes and its associated complications in Vietnam: an estimation using national health insurance claims from a cross-sectional survey. Kieu TTM; Trinh HN; Pham HTK; Nguyen TB; Ng JYS BMJ Open; 2020 Mar; 10(3):e032303. PubMed ID: 32132135 [TBL] [Abstract][Full Text] [Related]
7. Is hypoglycemia expensive in China? Lan K; Wang J; Nicholas S; Tang Q; Chang A; Xu J Medicine (Baltimore); 2021 Feb; 100(5):e24067. PubMed ID: 33592860 [TBL] [Abstract][Full Text] [Related]
8. The direct medical cost of type 2 diabetes mellitus in South Africa: a cost of illness study. Erzse A; Stacey N; Chola L; Tugendhaft A; Freeman M; Hofman K Glob Health Action; 2019; 12(1):1636611. PubMed ID: 31282315 [No Abstract] [Full Text] [Related]
9. Relationship of diabetes complications severity to healthcare utilization and costs among Medicare Advantage beneficiaries. Hazel-Fernandez L; Li Y; Nero D; Moretz C; Slabaugh L; Meah Y; Baltz J; Patel NC; Bouchard JR Am J Manag Care; 2015 Jan; 21(1):e62-70. PubMed ID: 25880269 [TBL] [Abstract][Full Text] [Related]
10. A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US. St Charles M; Minshall ME; Pandya BJ; Baran RW; Tunis SL Curr Med Res Opin; 2009 Jun; 25(6):1343-53. PubMed ID: 19419339 [TBL] [Abstract][Full Text] [Related]
11. Longitudinal Changes in Medical Services and Related Costs in a Single Cohort of Patients Newly Diagnosed With Type 2 Diabetes, 2006 to 2012. Weng W; Liang Y; Kimball ES; Hobbs T; Kong S; Sakurada B; Bouchard J Clin Ther; 2016 Jun; 38(6):1314-1326. PubMed ID: 27129399 [TBL] [Abstract][Full Text] [Related]
12. The Cost of Hypoglycemia Associated With Type 2 Diabetes Mellitus in Taiwan. Strizek A; Chang CJ; Furnback W; Wang B; Lebrec J; Lew T Value Health Reg Issues; 2019 May; 18():84-90. PubMed ID: 30776767 [TBL] [Abstract][Full Text] [Related]
13. Health care resource utilization and costs during episodes of care for type 2 diabetes mellitus-related comorbidities. Candrilli SD; Meyers JL; Boye K; Bae JP J Diabetes Complications; 2015; 29(4):529-33. PubMed ID: 25660136 [TBL] [Abstract][Full Text] [Related]
14. Indonesia Cohort of IO HAT Study to Evaluate Diabetes Management, Control, and Complications in Retrospective and Prospective Periods Among Insulin-Treated Patients with Type 1 and Type 2 Diabetes. Rudijanto A; Saraswati MR; Yunir E; Kumala P; Puteri HH; Mandang VV Acta Med Indones; 2018 Jan; 50(1):26-37. PubMed ID: 29686173 [TBL] [Abstract][Full Text] [Related]
15. Direct and indirect costs of acute diarrhea in children under five years of age in Indonesia: Health facilities and community survey. At Thobari J; Sutarman ; Mulyadi AWE; Watts E; Carvalho N; Debellut F; Clark A; Soenarto Y; Bines JE Lancet Reg Health West Pac; 2022 Feb; 19():100333. PubMed ID: 35024664 [TBL] [Abstract][Full Text] [Related]
16. Direct cost of patients with type 2 diabetes mellitus healthcare and its complications in Lithuania. Domeikienė A; Vaivadaitė J; Ivanauskienė R; Padaiga Ž Medicina (Kaunas); 2014; 50(1):54-60. PubMed ID: 25060205 [TBL] [Abstract][Full Text] [Related]
17. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. Plosker GL; Figgitt DP Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124 [TBL] [Abstract][Full Text] [Related]
18. The burden of severe hypoglycemia in type 2 diabetes. Liu J; Wang R; Ganz ML; Paprocki Y; Schneider D; Weatherall J Curr Med Res Opin; 2018 Jan; 34(1):179-186. PubMed ID: 29017368 [TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness Analysis of Type 2 Diabetes Mellitus (T2DM) Treatment in Patients with Complications of Kidney and Peripheral Vascular Diseases in Indonesia. Priyadi A; Permana H; Muhtadi A; Sumiwi SA; Sinuraya RK; Suwantika AA Healthcare (Basel); 2021 Feb; 9(2):. PubMed ID: 33669379 [TBL] [Abstract][Full Text] [Related]
20. Economic burden of managing Type 2 diabetes mellitus: Analysis from a Teaching Hospital in Malaysia. Ismail A; Suddin LS; Sulong S; Ahmed Z; Kamaruddin NA; Sukor N Indian J Public Health; 2017; 61(4):243-247. PubMed ID: 29219128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]